Senseonics (NYSE:SENS) Shares Scheduled to Reverse Split on Monday, October 20th

Shares of Senseonics Holdings, Inc. (NYSE:SENS) are set to reverse split before the market opens on Monday, October 20th. The 1-20 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Sunday, October 19th.

Senseonics Stock Performance

Shares of NYSE SENS opened at $0.42 on Friday. The firm has a 50 day moving average of $0.46 and a 200 day moving average of $0.53. The company has a current ratio of 2.47, a quick ratio of 2.38 and a debt-to-equity ratio of 59.17. The firm has a market capitalization of $342.17 million, a price-to-earnings ratio of -3.23 and a beta of 0.83. Senseonics has a 12-month low of $0.25 and a 12-month high of $1.40.

Analyst Ratings Changes

Several brokerages recently issued reports on SENS. HC Wainwright restated a “buy” rating and set a $1.40 target price (up from $1.10) on shares of Senseonics in a research report on Tuesday, July 8th. Barclays started coverage on shares of Senseonics in a research report on Wednesday, August 27th. They set an “overweight” rating and a $1.50 target price for the company. Lake Street Capital raised shares of Senseonics to a “strong-buy” rating in a report on Thursday, July 17th. Finally, TD Cowen started coverage on shares of Senseonics in a report on Tuesday, July 15th. They set a “buy” rating and a $1.25 price target on the stock. Two analysts have rated the stock with a Strong Buy rating and three have assigned a Buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $1.54.

Hedge Funds Weigh In On Senseonics

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. IFP Advisors Inc raised its stake in Senseonics by 120.9% during the first quarter. IFP Advisors Inc now owns 47,500 shares of the company’s stock valued at $31,000 after purchasing an additional 26,000 shares in the last quarter. CTC Alternative Strategies Ltd. purchased a new stake in Senseonics during the first quarter valued at $31,000. Two Sigma Investments LP purchased a new stake in Senseonics during the fourth quarter valued at $36,000. Smith Salley Wealth Management purchased a new stake in Senseonics during the first quarter valued at $36,000. Finally, Elite Life Management LLC purchased a new stake in Senseonics during the second quarter valued at $36,000. Institutional investors own 12.36% of the company’s stock.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.